Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKinovo Plc Regulatory News (KINO)

  • This share is currently suspended. It was suspended at a price of 87.00
  • There is currently no data for KINO

Trading Update

9 Feb 2024 07:00

RNS Number : 5649C
Kinovo PLC
09 February 2024
 

9 February 2024

 

Kinovo plc

("Kinovo", the "Company" or the "Group")

 

Trading Update

 

Kinovo plc (AIM:KINO), the specialist property services Group that delivers compliance and sustainability solutions, provides the following trading update. The continuing business continues to perform well with particularly strong margins reflecting the mix of works and continued effects of management's implementation of the strategic repositioning.

 

The Group continues to make progress in East Anglia having opened a new office in December 2023, and has secured eight contracts with new clients via the Eastern Procurement Asset Improvement framework. Six of these are for a term of between one and three years, amounting to a total expected value of approximately £4.2 million. The remaining contracts are initially for a shorter term, although the expectation is that they hold the potential for longer term contracts to be agreed in the new financial year. The Company remains in conversations with several other potential clients in East Anglia and continues to invest to further its growth in the region.

 

The Group continues its strong trajectory of new client acquisition and extensions with existing customers. It has secured a contract extension with Sanctuary Group for compliance-related works for FY25, with a potential to extend this contract for a further year. The Group continues to diversify its client base, winning short-term direct awards with Newlon Housing Trust and Qualis Property Solutions, initially for compliance works but with scope for a wider offering in the future. Furthermore, under the Greener Future Partnership framework, Kinovo has been awarded a further 109 surveys after the successful completion of the first wave of surveys for Hyde Housing's retrofit program.

 

Discontinued Operations

 

Three of the legacy projects relating to Kinovo's former construction division, DCB Kent ("DCB"), have concluded. A further four projects have been delayed by extreme weather and unforeseen inherited remedial works and are now expected to be completed by the end of Kinovo's financial year. The penultimate project is in progress and is expected to complete by the end of May 2024, and the Group remains in discussions with the client regarding the final project (due to complete in 2026).

 

As a result of these delays, the total net costs incurred have increased to £7.1 million as at 31 December 2023 including additional procurement, warranty and remedial costs. Kinovo are seeking to recover some of the additional costs incurred through claims and recoveries, but the total pre-tax net cost to complete is therefore expected to be a material increase from the previous estimate of £5.72 million. We will update the market in due course on all material matters relating to the DCB projects if or when they may occur.

 

Outlook

 

Without accounting for additional works crystalising from Kinovo's pipeline as the Group enters its peak trading season, revenues for the year ending 31 March 2024 for continuing operations are expected to be approximately £65 million (FY23: £62.7 million), reflecting a different revenue mix of projects contracted to date, with electrical services continuing to perform strongly. Adjusted EBITDA is expected to be significantly ahead of last year (FY23: £5.5 million) and not less than £6.2 million, being in line with management expectations. This demonstrates the Board's continued confidence in the strength and resilience of the continuing business and its significant growth potential. Cash balances will reflect the aforementioned costs incurred and the outcome of any potential recoveries from the DCB projects, supplemented by cash generation from the continuing business.

 

 

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

 

Enquiries

Kinovo plc

Sangita Shah, Chairman

David Bullen, Chief Executive Officer

+44 (0)20 7796 4133

(via Hudson Sandler)

Canaccord Genuity Limited (Nominated Adviser and Sole Broker)

+44 (0)20 7523 8000

Adam James

Andrew Potts

Harry Rees

Hudson Sandler (Financial PR)

+44 (0)20 7796 4133

Dan de Belder

Harry Griffiths

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFFFFSITIIS
Date   Source Headline
5th Sep 20237:00 amRNSRenewal of Bank Facilities
4th Sep 202311:10 amRNSForm 8.5 (EPT/RI) - Kinovo PLC
1st Sep 202312:51 pmRNSForm 8.3 - KINOVO PLC
1st Sep 202312:37 pmRNSForm 8 (OPD) (Rx3 Holdings Limited)
1st Sep 202311:00 amRNSStatement regarding possible offer
1st Sep 202310:26 amRNSForm 8.5 (EPT/RI)
31st Aug 20236:29 pmRNSTotal Voting Rights
31st Aug 20236:29 pmRNSForm 8.3 - Kinovo plc
31st Aug 20234:55 pmRNSForm 8.3 - Kinovo PLC
31st Aug 20239:53 amRNSForm 8.5 (EPT/RI)
31st Aug 20237:00 amRNSResult of AGM
30th Aug 202310:00 amRNSForm 8.5 (EPT/RI)
30th Aug 20237:00 amRNSPossible offer for Kinovo plc
29th Aug 20232:27 pmRNSForm 8.3 - Kinovo PLC
29th Aug 202310:31 amRNSForm 8.3 - KINOVO PLC
29th Aug 202310:08 amRNSForm 8.5 (EPT/RI) - Kinovo PLC
25th Aug 20233:24 pmRNSForm 8.3 - Kinovo plc
25th Aug 202312:06 pmRNSForm 8.3 - Kinovo PLC
25th Aug 202311:54 amPRNForm 8.3 - Kinovo Plc
25th Aug 20239:10 amRNSForm 8.5 (EPT/RI)
25th Aug 20237:00 amRNSShare Incentive Plan, Director/PDMR Shareholding
25th Aug 20237:00 amRNSRule 2.9 announcement
25th Aug 20237:00 amRNSStatement regarding minimum potential offer
24th Aug 20232:14 pmRNSForm 8.3 - Kinovo plc
24th Aug 20231:00 pmRNSStatement regarding possible offer
4th Aug 20235:20 pmRNSAnnual Report and Notice of Annual General Meeting
19th Jul 20237:00 amRNSHolding(s) in Company
11th Jul 20237:00 amRNSFinal results for the year ended 31 March 2023
7th Jul 20237:00 amRNSNotice of Results & Investor Presentation
3rd Jul 20237:00 amRNSHolding(s) in Company
29th Jun 202310:58 amRNSHolding(s) in Company
22nd May 20237:00 amRNSAdditional Framework and Contracts Wins
17th May 20237:00 amRNSTrading Update
28th Feb 202312:00 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSContract Win and NHMF Net Zero Carbon Framework
23rd Jan 20237:00 amRNSLondon Borough of Waltham Forest Contract Win
17th Jan 20237:00 amRNSHighest-ranking regional contractor awards
5th Dec 20227:00 amRNSNotice of Investor Presentation
28th Nov 20227:00 amRNSInterim Results
15th Nov 20227:00 amRNSNotice of Results
5th Oct 20227:00 amRNSRenewal of Debt Facilities
15th Sep 202212:06 pmRNSResult of AGM and Directorate change
15th Sep 20227:00 amRNSAGM Trading Update
13th Sep 202211:41 amRNSDirector/PDMR Shareholding
12th Sep 20228:18 amRNSHolding(s) in Company
26th Aug 20227:54 amRNSShare Incentive Plan purchase
23rd Aug 20222:38 pmRNSAnnual Report and Notice of Annual General Meeting
19th Aug 20222:05 pmRNSSecond Price Monitoring Extn
19th Aug 20222:00 pmRNSPrice Monitoring Extension
19th Aug 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.